Status:
COMPLETED
Stem Cell Educator Therapy in Type 2 Diabetes
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
Chinese government
Jinan Tianhe Stem Cell Biotechnologies Co Ltd
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
14-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Type 2 diabetes is the most common form of diabetes. The prevalence of diabetes has been markedly increased in recent years. More and more children and young adults develop this devastating disease. D...
Eligibility Criteria
Inclusion
- Patients were screened for enrollment in the study if both clinical signs and laboratory tests meet the diagnosis standards of American Diabetes Association 2010. Other key inclusion criteria were presence of at least one autoantibody to the pancreatic islet β cells for the autoimmune-related type 2 diabetes.
Exclusion
- Exclusion criteria were any clinically significant diseases in liver, kidney, and heart. Additional exclusion criteria were no pregnancy, no immunosuppressive medication, no viral diseases or diseases associated with immunodeficiency.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01415726
Start Date
July 1 2011
End Date
February 1 2012
Last Update
February 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Jinan Military Command
Jinan, Shandong, China, 250031